School of Nursing, 36674Dalian Medical University, Dalian, China.
School of Nursing, 26680The Hong Kong Polytechnic University, Hong Kong SAR, China.
Cancer Control. 2022 Jan-Dec;29:10732748221115469. doi: 10.1177/10732748221115469.
The global pandemic has caused breast cancer (BC) patients who are receiving chemotherapy to face more challenges in taking care of themselves than usual. A novel nurse-led mHealth program (mChemotherapy) is designed to foster self-management for this population. The aim of the pilot study is to determine the feasibility, usability, and acceptability of an mChemotherapy program for breast cancer patients undergoing chemotherapy. The objective also is to evaluate the preliminary effects of this program on adherence to app usage, self-efficacy, quality of life, symptom burden, and healthcare utilization among this group of patients.
This is a single-blinded randomized controlled pilot study that includes one intervention group (mChemotherapy group) and one control group (routine care group). Ninety-four breast cancer patients who commence chemotherapy in a university-affiliated hospital will be recruited. Based on the Individual and Family Self-management Theory, this 6-week mChemotherapy program, which includes a combination of self-regulation activities and nurse-led support, will be provided. Data collection will be conducted at baseline, week 3 (T1), and week 6 (T2). A general linear model will be utilized for identifying the between-group, within-group, and interaction effects. Qualitative content analysis will be adopted to analyze, extract, and categorize the interview transcripts.
Breast cancer patients receiving chemotherapy are a population that often experiences a heavy symptom burden. During the pandemic, they have had difficulties in self-managing the side effects of chemotherapy due to the lack of face-to-face professional support. An mChemotherapy program will be adopted through a self-regulation process and with the provision of nurse-led real-time professional support for these patients. If proven effective, BC patients who engage in this program will be more likely to take an active role in managing their symptoms, take responsibility for their own health, and subsequently improve their self-efficacy and adherence to the use of the app.
全球大流行使得正在接受化疗的乳腺癌(BC)患者在自我护理方面面临比以往更多的挑战。一个新的护士主导的移动医疗(mHealth)项目(mChemotherapy)旨在为这一人群培养自我管理能力。该试点研究的目的是确定针对正在接受化疗的乳腺癌患者的 mChemotherapy 项目的可行性、可用性和可接受性。其目的还在于评估该方案对该人群的应用程序使用依从性、自我效能、生活质量、症状负担和医疗保健利用的初步效果。
这是一项单盲随机对照试点研究,包括一个干预组(mChemotherapy 组)和一个对照组(常规护理组)。将招募 94 名在一所大学附属医院开始化疗的乳腺癌患者。该 6 周的 mChemotherapy 方案基于个体和家庭自我管理理论,包括自我调节活动和护士主导的支持相结合。将在基线、第 3 周(T1)和第 6 周(T2)进行数据收集。将使用一般线性模型来确定组间、组内和交互效应。将采用定性内容分析来分析、提取和分类访谈记录。
正在接受化疗的乳腺癌患者是一个经常经历沉重症状负担的人群。在大流行期间,由于缺乏面对面的专业支持,他们在自我管理化疗副作用方面遇到了困难。将通过自我调节过程并为这些患者提供护士主导的实时专业支持来采用 mChemotherapy 方案。如果证明有效,参与该计划的 BC 患者将更有可能积极管理自己的症状,对自己的健康负责,从而提高自我效能和应用程序使用的依从性。